{
  "ptid_time": "094_S_4737_2012-08-28",
  "img_path": "/data/qiuhui/data/adni/images/094_S_4737/2012-08-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 43,747 mm³, 55.9% above the reference mean. With a Z-score of 1.28 (90.0th percentile), this represents mild enlargement; hippocampal volume measures 5,648 mm³, 20.6% below the reference mean. With a Z-score of -1.89 (2.9th percentile), this represents moderate atrophy; whole brain volume measures 883,897 mm³, 9.3% below the reference mean. With a Z-score of -1.17 (12.1th percentile), this represents mild atrophy. ",
  "text_data": "Age is 74.3 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Endocrine-Metabolic. MMSE: 23.0. MoCA: 20.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.14 SUVR (normal ); Amyloid beta: 611.80 pg/mL (mild reduced); Total tau: 294.60 pg/mL (normal ); Phosphorylated tau: 26.50 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits moderate hippocampal atrophy and mild whole brain atrophy, along with mild ventricular enlargement, which are structural changes commonly associated with Alzheimer's disease (AD). The cognitive scores (MMSE 23, MoCA 20) indicate mild cognitive impairment, and the presence of one APOE4 allele and mildly reduced Aβ further support AD pathology, though tau markers are normal.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**, likely due to Alzheimer’s disease.  \n\n**Confidence:** **Medium** (due to normal tau and AV45, but strong structural and cognitive evidence).",
  "timestamp": "2025-07-26T10:34:04.044778"
}